title: Tachykinins and tachykinin receptors in human uterus.
abstract: (1) Studies were undertaken to determine the nature of the receptors mediating contractile effects of tachykinins in the uteri of nonpregnant women, and to analyse the expression of preprotachykinins (PPT), tachykinin receptors and the cell-surface peptidase, neprilysin (NEP), in the myometrium from pregnant and nonpregnant women. (2) The neurokinin B (NKB) precursor PPT-B was expressed in higher levels in the myometrium from nonpregnant than from pregnant women. Faint expression of PPT-A mRNA was detectable in the myometrium from nonpregnant but not pregnant women. PPT-C, the gene encoding the novel tachykinin peptide hemokinin-1 (HK-1), was present in trace amounts in the uteri from both pregnant and nonpregnant women. (3) Tachykinin NK(2) receptors were more strongly expressed in tissues from nonpregnant than from pregnant women. NK(1) receptor mRNA was present in low levels in tissues from both pregnant and nonpregnant women. A low abundance transcript corresponding to the NK(3) receptor was present only in tissues from nonpregnant women. (4) The mRNA expression of the tachykinin-degrading enzyme NEP was lower in tissues from nonpregnant than from pregnant women. (5) Substance P (SP), neurokinin A (NKA) and NKB, in the presence of the peptidase inhibitors thiorphan, captopril and bestatin, produced contractions of myometrium from nonpregnant women. The order of potency was NKA>>SP>/=NKB. The potency of NKA was unchanged in the absence of peptidase inhibitors. (6) The tachykinin NK(2) receptor-selective agonist [Lys(5)MeLeu(9)Nle(10)]NKA(4-l0) was approximately equipotent with NKA, but the tachykinin NK(1) and NK(3) receptor-selective agonists [Sar(9)Met(O(2))(11)]SP and [MePhe(7)]NKB were ineffective in the myometrium from nonpregnant women. (7) The uterotonic effects of [Lys(5)MeLeu(9)Nle(10)]NKA(4-10) were antagonized by the tachykinin NK(2) receptor-selective antagonist SR48968. Neither atropine, nor phentolamine nor tetrodotoxin affected responses to [Lys(5)MeLeu(9)Nle(10)]NKA(4-10). (8) These data are consistent with a role of tachykinins in the regulation of human uterine function, and reinforce the importance of NK(2) receptors in the regulation of myometrial contraction.
authors.affiliation: Department of Anaesthetics, Royal Women's Hospital, Carlton, Victoria 3053, Australia.
authors.forename: Eva
authors.initials: E
authors.lastname: Patak
authors.forename: M Luz
authors.initials: ML
authors.lastname: Candenas
authors.forename: Jocelyn N
authors.initials: JN
authors.lastname: Pennefather
authors.forename: Sebastian
authors.initials: S
authors.lastname: Ziccone
authors.forename: Alison
authors.initials: A
authors.lastname: Lilley
authors.forename: Julio D
authors.initials: JD
authors.lastname: Martín
authors.forename: Carlos
authors.initials: C
authors.lastname: Flores
authors.forename: Antonio G
authors.initials: AG
authors.lastname: Mantecón
authors.forename: Margot E
authors.initials: ME
authors.lastname: Story
authors.forename: Francisco M
authors.initials: FM
authors.lastname: Pinto
mesh_terms: D000328:Adult; D000368:Aged; D000704:Analysis of Variance; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D008875:Middle Aged; D009119:Muscle Contraction / Q000187:drug effects / Q000502:physiology; D015260:Neprilysin / Q000494:pharmacology; D011247:Pregnancy; D012333:RNA, Messenger / Q000096:biosynthesis / Q000235:genetics; D018039:Receptors, Tachykinin / Q000819:agonists / Q000037:antagonists & inhibitors / Q000096:biosynthesis* / Q000235:genetics; D015320:Tachykinins / Q000494:pharmacology*; D014599:Uterus / Q000187:drug effects* / Q000378:metabolism*
chemical_list: D012333:RNA, Messenger; D018039:Receptors, Tachykinin; D015320:Tachykinins; D015260:Neprilysin